As 2025 draws to a close, the healthcare mergers and acquisitions (“M&A”) market remains active but increasingly selective. After two years of recalibration following the post-pandemic boom, dealmakers are navigating a landscape shaped by persistent cost pressures, evolving regulation, and renewed interest in technology-enabled care. While deal volume has softened compared with the highs of 2021–22, investor appetite for well-positioned assets remains strong. Strategic buyers and private equity sponsors are focusing on quality over quantity — emphasizing synergies, scalability, and innovation.
Read the full article: Healthcare M&A Outlook: Q4 2025 and The Road Ahead to 2026 //
Source: https://www.jdsupra.com/legalnews/healthcare-m-a-outlook-q4-2025-and-the-4712891/